AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-102708660/trends-amp-innovations-point.html" title="Facts and information about TRENDS & INNOVATIONS.(TO THE POINT)">TRENDS & INNOVATIONS.(TO THE POINT)</a>
Close
Set up an RSS feed that alerts you when new articles from Investor's Business Daily are available.
Frequently asked questions about RSS feeds
TRENDS & INNOVATIONS.(TO THE POINT)
** British researchers developed an adhesive based on the sticky feet of geckos, little lizards that have millions of tiny hairs called setae on their feet, Nature Materials said.
** The FDA will hold a public meeting June 26 to discuss ways to prevent medication errors caused by similar drug names, like testing a brand name's potential for causing confusion before filing for FDA OK.
** Children's HIV risk after being accidentally exposed to the virus is low, so doctors shouldn't automatically give anti-HIV drugs to kids post-exposure, Pediatrics reported.
** ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- FDA ok.(Friday, March 2)(Food and Drug Administration)(Procleix Tigris...
- Magazine article from: San Diego Business Journal Weeks, Katie March 12, 2007 700+ words
FDA OK: Gen-Probe Inc. announced the Food and Drug Administration has approved the San Diego-based company's device to test donated...
- Pfizers FDA OK To Begin Glaucoma Drug Candidate Study, Triggers Payment To...
- News wire article from: The America's Intelligence Wire March 29, 2007 700+ words
(From FinancialWire) Byline: DAVID WEBER FinancialWire-29 March 2007-Pfizers FDA OK To Begin Glaucoma Drug Candidate Study, Triggers Payment To NicOx (C)2007 Investrend Communications, Inc. March 29, 2007...
- FDA OK.(United States. Food and Drug Administration)(Brief article)
- Magazine article from: San Diego Business Journal Weeks, Katie September 4, 2006 700+ words
FDA OK: San Diego's DexCom Inc. received approval from the Food and Drug Administration for a software program used to help diabetes patients manage glucose levels.
- Bio-Data gets FDA ok to market product. (Bio-Data Corp.) (product announcement)
- Magazine article from: Philadelphia Business Journal Reichert, Kent December 14, 1987 700+ words
Bio/Data gets FDA OK to market product Hatboro-based Bio/Data Corp. has received clearance from the Food and Drug Administration (FDA) to market...
- Dr. Reddys Gets FDA OK For Generic Famotidine 20 MG.
- News wire article from: The America's Intelligence Wire September 28, 2006 700+ words
(From FinancialWire) FinancialWire-28 September 2006-Dr. Reddys Gets FDA OK For Generic Famotidine 20 MG (C)2006 Investrend Communications, Inc. September 28, 2006 (FinancialWire) Leiner Health Products...
- Amplatzer device gets FDA OK to close VSD holes in the heart.
- Magazine article from: Medical Device Week September 12, 2007 700+ words
Amplatzer device gets FDA OK to close VSD holes in the heart By OMAR FORD Medical Device Daily Staff Writer Look at the facts. Any physician will quickly point...
- GW Medical, assuming FDA OK, set to market 1st AD blood test.
- Magazine article from: Medical Device Week April 8, 2005 700+ words
GW Medical, assuming FDA OK, set to market 1st AD blood test By KAREN YOUNG Medical Device Daily Staff Writer If all goes as planned, GW Medical Technologies...
- Merck Has Hopes for Arcoxia, But FDA OK May Not Be Among Them.
- News wire article from: The America's Intelligence Wire October 20, 2004 700+ words
(From FinancialWire) FinancialWire-20 October 2004-Merck Has Hopes for Arcoxia, But FDA OK May Not Be Among Them (C)2004 Investrend Communications, Inc. October 20, 2004. (FinancialWire) Mercks (NYSE: MRK...
- Genzyme Releases Promising Results for Kidney Drug and Gilead's Letairis...
- Press release article from: M2 Presswire June 19, 2007 700+ words
...19 June 2007-U.S. Equity News: Genzyme Releases Promising Results for Kidney Drug and Gilead's Letairis Tablets Get FDA OK(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:19062007 City of Industry, CA - Biotechnology industry alert provided by U...
- FDA OK 300mg loading dose of Sanofi's Plavix.
- Newspaper article from: Pharma Marketletter September 27, 2007 700+ words
Sanofi-Aventis and Bristol-Myers Squibb say that the US Food and Drug Administration has approved a supplemental New Drug Application for a 300mg tablet of their antiplatelet agent Plavix (clopidogrel The 300mg tablet will facilitate the use of the FDA-approved loading dose for appropriate acute
